| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |